Key result
Taiwanese HCM features a distinct genetic landscape with unique variants and notable Fabry disease burden.
Why the study?
The genetic profile of hypertrophic cardiomyopathy has been well studied in Western populations, but data from East Asia, particularly Taiwan, remain limited.
Observational study reveals distinct genetic variants and Fabry disease burden in Taiwanese individuals with hypertrophic cardiomyopathy, highlighting regional differences in heart disease genetics.
Hypertrophic cardiomyopathy (HCM) is a complex cardiac disorder characterized by abnormal loading conditions and increased risk of adverse cardiovascular outcomes. The genetic profile of HCM has been well studied in Western populations, but data from East Asia, particularly Taiwan, remain limited.
No takes yet. Share an insight, caveat, or question.
Kuang-Huan Cheng (2026) studied this question. Hypertrophic cardiomyopathy in Taiwan exhibits a distinct genetic landscape characterized by population-specific variants and a notable burden of Fabry disease.
Synapse has enriched 5 related papers. Consider them for comparative context: